Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-β /Activin Receptor-Like Kinase 1 (TGF-β /ALK1) Signaling: Relevance to the Brain Disposition of 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors (i.e., Statins).
Drug Metab Dispos. 2022 May 3:DMD-AR-2021-000781. doi: 10.1124/dmd.121.000781. Online ahead of print.
Drug Metab Dispos. 2022.
PMID: 35504656
Free article.